Investopedia: PerkinElmer Adds High-End Tools To Its Box

Investors who were absorbed in watching the tech sector meltdown in 2000 might not have been aware that as tech was falling apart, another bubble rapidly emerged. With the promise and hype of genomics and proteomics fueling dreams of a revolution in medicine, a host of life science companies IPO'd with robust valuations, promising technology and little-to-nothing in the way of actual revenue.

Like every other bubble, this popped and investors have been dealing with the wreckage ever since. Clearly companies like Illumina (Nasdaq:ILMN) have gone on to great success, while others went out of business entirely. And then there were companies like Caliper Life Sciences (Nasdaq:CALP) that could never quite live up to the initial hype, but eventually developed their technology to a point where they were interesting second-chance stocks.


Read more through the link below:
http://stocks.investopedia.com/stock-analysis/2011/PerkinElmer-Adds-High-End-Tools-To-Its-Box-PKI-ILMN-CALP-PFE-LIFE-CPHD-A0912.aspx